← Eichor
Study identifier: NCT07102160 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Condition: Deep Vein Thrombosis (DVT) · Thrombus in the Peripheral Venous Vasculature · Venous Embolism  ·  Sponsor: Argon Medical Devices

PhaseN/A
Planned participants185
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac® Thrombectomy System for the treatment of thrombus in patients with lower extremity proximal deep vein thrombosis (DVT). This prospective, multi-center, open-label study will assess clinical outcomes, device performance, and procedural success in a single DVT study cohort.

This description comes directly from the study's public registry record.

Talk to the study team

Esther Ajasa, MS  ·  469-423-2280  ·  clinical@argonmedical.com

Holly Harrison  ·  (469) 731-3561  ·  clinical@argonmedical.com

Always discuss trial participation with your own doctor first.

Locations (4)

Janna, LLCFort Lauderdale, Florida, United StatesRecruiting
Baycare Health SystemTampa, Florida, United StatesRecruiting
St. Elizabeth Healthcare - EdgewoodEdgewood, Kentucky, United StatesRecruiting
Baylor Scott & White The Heart Hospital - PlanoPlano, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07102160